| Literature DB >> 17573960 |
Ping-Ho Chen1, Tien-Yu Shieh, Pei-Shan Ho, Chi-Cheng Tsai, Yi-Hsin Yang, Ying-Chu Lin, Min-Shan Ko, Pei-Chien Tsai, Shang-Lun Chiang, Hung-Pin Tu, Ying-Chin Ko.
Abstract
BACKGROUND: In Taiwan, a distinct ethnic group variation in incidence and mortality rates has been suggested for most carcinomas. Our aim is to identify the role of prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan.Entities:
Mesh:
Year: 2007 PMID: 17573960 PMCID: PMC1931441 DOI: 10.1186/1471-2407-7-101
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Characteristics of oral and pharyngeal carcinoma subjects (N = 9039) at time of diagnosis in Taiwan from 1985–1994.
| Ethnic group | Aborigines community (N = 302) | Hakka community (N = 556) | Hokkien community (N = 8181) | |
| Characteristics | N(%)a | N(%)a | N(%)a | |
| Period of diagnosis (yrs) | ||||
| 1985–1989 | 119(39.4) | 196(35.3) | 2864(35.0) | 0.2908 |
| 1990–1994 | 183(60.6) | 360(64.8) | 5317(65.0) | |
| Gender | ||||
| Males | 233(77.2) | 467(84.0) | 7280(89.0) | < 0.0001 |
| Females | 69(22.9) | 89(16.0) | 901(11.0) | |
| Diagnostic age (yrs) | ||||
| < = 49 | 69(22.9) | 178(32.0) | 3021(36.9) | < 0.0001 |
| 50–59 | 87(28.8) | 149(26.8) | 2320(28.4) | |
| 60–69 | 82(27.2) | 142(25.5) | 1812(22.2) | |
| > = 70 | 64(21.2) | 87(15.7) | 1028(12.6) | |
| Anatomic site | ||||
| Lip | 11(3.6) | 19(3.4) | 296(3.6) | < 0.0001 |
| Tongue | 63(20.9) | 162(29.1) | 2333(28.5) | |
| Mouth | 128(42.4) | 246(44.2) | 3571(43.7) | |
| Oropharyngeal | 16(5.3) | 51(9.2) | 651(8.0) | |
| Hypopharyngeal | 81(26.8) | 71(12.8) | 1255(15.3) | |
| Other | 3(1.0) | 7(1.3) | 72(0.9) | |
| Morphologic type | ||||
| SCC | 267(88.4) | 456(82.0) | 7020(85.8) | 0.0229 |
| Verrucous carcinoma | 14(4.6) | 24(4.3) | 344(4.2) | |
| Other carcinoma | 21(7.0) | 76(13.7) | 817(10.0) | |
| Therapy | ||||
| Surgery alone | 58(19.2) | 158(28.4) | 1976(24.2) | 0.0188 |
| RT alone | 17(5.6) | 42(7.6) | 568(6.9) | |
| CT alone | 23(7.6) | 48(8.6) | 694(8.5) | |
| Surgery + RT | 34(11.3) | 43(7.7) | 756(9.2) | |
| Surgery + CT | 15(5.0) | 29(5.2) | 524(6.4) | |
| RT + CT | 16(5.3) | 24(4.3) | 440(5.4) | |
| Surgery + RT + CT | 16(5.3) | 25(4.5) | 344(4.2) | |
| ST alone | 22(7.3) | 21(3.8) | 269(3.3) | |
| Other complex therapy | 101(33.4) | 166(29.9) | 2610(31.9) | |
SCC: squamous cell carcinoma.
RT: radiation therapy; CT: chemotherapy; ST: supportive care therapy.
a May not total 100% due to rounding.
Figure 1Survival days for 302 Aborigines community (130 deaths), 556 Hakka community (215 deaths) and 8181 Hokkien community (3761 deaths), according to oral and pharyngeal carcinoma deaths (N = 4106), which act as endpoints (p = 0.0051).
Figure 2(A) Survival days for 233 Aborigines community males (98 deaths), 467 Hakka community males (193 deaths) and 7280 Hokkien community males (3469 deaths), according to oral and pharyngeal carcinoma deaths (N = 3760), which act as endpoints (p = 0.0114). (B) Survival days for 69 Aborigines community females (32 deaths), 89 Hakka community females (22 deaths) and 901 Hokkien community females (292 deaths), according to oral and pharyngeal carcinoma deaths (N = 346), which act as endpoints (p = 0.0123).
Figure 3Survival days of mouth site for 128 Aborigines community (67 deaths), 246 Hakka community (94 deaths) and 3571 Hokkien community (1700 deaths), according to oral and pharyngeal carcinoma deaths (N = 1861), which act as endpoints (p = 0.0100).
Unadjusted and adjusted hazard ratio for oral and pharyngeal carcinoma death in Taiwan from 1985–1994.
| Oral and pharyngeal carcinoma death (N = 4106) | ||
| Ethnic group | Aborigines: Hakkaa HR (95% CI) | Hokkien: Hakkab HR (95% CI) |
| Unadjusted HR | 1.16 (0.93–1.44) | 1.25 (1.09–1.43)* |
| Adjusted HR | ||
| Adjusted for the period of diagnosis (yrs) | 1.16 (0.93–1.44) | 1.25 (1.09–1.43)* |
| Above plus gender, diagnostic age | 1.18 (0.95–1.46) | 1.22 (1.06–1.40)* |
| Above plus anatomic site, morphological type, therapy | 1.07 (0.86–1.33) | 1.16 (1.01–1.33)* |
HR: hazard ratio; CI = confidence interval.
* Statistical significance (p < 0.05).
a Aborigines community-to-Hakka community ratio.
b Hokkien community-to-Hakka community ratio.
Multivariate proportional hazard ratio for oral and pharyngeal carcinoma death in Taiwan from 1985–1994.
| Oral and pharyngeal carcinoma death (N = 4106) | |||
| Ethnic group | Aborigines community (N = 130) | Hakka community (N = 215) | Hokkien community (N = 3761) |
| Characteristics | HR(95% CI) | HR(95% CI) | HR(95% CI) |
| Period of diagnosis (yrs) | |||
| 1985–1989 | 1.00 | 1.00 | 1.00 |
| 1990–1994 | 1.43(0.93–2.20) | 1.55(1.13–2.13)* | 1.20(1.12–1.29)* |
| Gender | |||
| Females | 1.00 | 1.00 | 1.00 |
| Males | 0.94(0.62–1.43) | 1.87(1.18–2.97)* | 1.60(1.42–1.81)* |
| Diagnostic age (yrs) | |||
| < = 49 | 1.00 | 1.00 | 1.00 |
| 50–59 | 1.17(0.71–1.92) | 1.12(0.77–1.61) | 0.96(0.89–1.04) |
| 60–69 | 1.24(0.74–2.08) | 1.19(0.83–1.73) | 0.99(0.90–1.08) |
| > = 70 | 1.05(0.59–1.87) | 2.46(1.62–3.73)* | 1.15(1.03–1.28)* |
| Anatomic site | |||
| Oropharyngeal | 1.00 | 1.00 | 1.00 |
| Lip | 1.22(0.33–4.55) | 0.52(0.17–1.61) | 0.77(0.61–0.98)* |
| Tongue | 0.94(0.37–2.37) | 1.36(0.77–2.41) | 1.31(1.14–1.50)* |
| Mouth | 0.89(0.37–2.15) | 1.18(0.67–2.07) | 1.26(1.10–1.43)* |
| Hypopharyngeal | 0.43(0.17–1.11) | 0.99(0.51–1.90) | 0.98(0.84–1.15) |
| Other | 0.00-a | 0.85(0.11–6.77) | 0.70(0.43–1.13) |
| Morphologic type | |||
| SCC | 1.00 | 1.00 | 1.00 |
| Verrucous carcinoma | 0.95(0.38–2.40) | 0.46(0.20–1.05) | 0.51(0.42–0.62)* |
| Other carcinoma | 0.63(0.30–1.35) | 0.35(0.20–0.62)* | 0.54(0.47–0.62)* |
| Therapy | |||
| Surgery alone | 1.00 | 1.00 | 1.00 |
| RT alone | 3.02(1.25–7.28)* | 3.03(1.70–5.40)* | 2.61(2.26–3.01)* |
| CT alone | 1.38(0.55–3.46) | 4.81(2.93–7.90)* | 2.74(2.41–3.12)* |
| Surgery + RT | 2.01(0.98–4.13) | 1.56(0.85–2.84) | 1.76(1.55–2.01)* |
| Surgery + CT | 1.21(0.46–3.13) | 2.40(1.30–4.45)* | 1.38(1.18–1.61)* |
| RT + CT | 5.38(2.26–12.83)* | 2.97(1.55–5.67)* | 3.49(3.02–4.03)* |
| Surgery + RT + CT | 3.76(1.60–8.83)* | 4.59(2.51–8.39)* | 2.58(2.20–3.01)* |
| ST alone | 3.78(1.69–8.43)* | 2.55(1.11–5.86)* | 3.05(2.53–3.69)* |
| Other complex therapy | 2.96(1.57–5.59)* | 2.46(1.61–3.74)* | 2.09(1.89–2.30)* |
SCC: squamous cell carcinoma; RT: radiation therapy; CT: chemotherapy; ST: supportive care therapy.
HR: hazard ratio; CI: confidence interval.
a No subjects died from other anatomic site.
*Statistical significance (p < 0.05).